Corcept Therapeutics | CORT - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Acadia Pharmaceuticals USD 3.98M 22.34M 2026-03
Alaunos Therapeutics USD -7.84M 633K 2023-12
ANI Pharmaceuticals USD 31.48M 18.04M 2025-12
Ardelyx USD -400K 467K 2025-12
Assertio Holdings USD -2.88M 648K 2024-09
Aurora Cannabis CAD -1.58M 48.55M 2025-12
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Bristol-Myers Squibb USD 1.47B 1.64B 2025-12
Canopy Growth CAD -62.26M 60.84M 2025-12
Corcept Therapeutics USD 9.91M 5.33M 2025-12
Eli Lilly USD 8.27B 1.03B 2025-12
Esperion Therapeutics USD 63.67M 95M 2025-12
J&J USD 7.82B 2.86B 2026-03
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Lexicon Pharmaceuticals USD -12.77M 16.02M 2025-09
Merck USD 3.42B 3.32B 2025-12
Nektar Therapeutics USD -34.7M 2.35M 2025-12
Novartis USD 3.84B 802M 2026-03
Novartis USD 5.17B 637M 2025-09
Omeros USD -65.12M 21.27M 2024-06
Pacira USD 571K 8.95M 2025-12
Pfizer USD 5.18B 6.82B 2026-03
Supernus Pharmaceuticals USD -5.95M 4.04M 2026-03
TG Therapeutics USD 20.36M 24.73M 2026-03